Advancement and Adjacent Expansion of Existing Businesses and Creation of New Businesses
First written in FY2016. 18 of 27 entries say "Restated". Latest entry: FY2026.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group has 589 R&D staff, representing approximately 7% of total employees.」
R&D expenses were ¥12,432 million, and R&D staff totaled 589 people. The company’s history also records the opening of the Production Technology Research Institute in April 2026, expanding its R&D infrastructure. - 2026-05-20ReframedResults presentation
「これまで分散していた各研究・開発部門の体制を集約し、CTOをトップとする全社横断のR&D体制へ移行。」
研究開発活動について、個別部門中心の体制から、CTOをトップとする全社横断体制へ整理し直されました。 - FY2025AdvancedAnnual report
「A new building, the Specialty Material Application Building, was constructed at the Osaka R&D Center.」
The construction of a new building at the Osaka R&D Center was reported as an expansion of the R&D infrastructure for developing composite materials, recycled materials and biopolymers. R&D expenses were ¥9,917 million, and R&D staff totaled 578 people. - FY2024AdvancedAnnual report
「Key achievements included the launch of the large two-platen servo-hydraulic machine (1300MMXⅡ-i120).」
As an R&D achievement, the Machinery business launched a large two-platen servo-hydraulic machine. - FY2024-Q2RestatedAnnual report
「Group-wide R&D expenses for the first half of the current consolidated fiscal year were ¥5,106 million. There were no material changes in the status of the Group’s R&D activities during the first half of the current consolidated fiscal year.」
No material changes were reported in R&D activities, and cumulative R&D expenses for the first half were ¥5,106 million. - FY2024-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated fiscal year were ¥2,614 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current consolidated fiscal year.」
No material changes were reported in R&D activities, and R&D expenses for the quarter were ¥2,614 million. - FY2023AdvancedAnnual report
「Key achievements included the launch of the 2,000-ton model (2000emⅢ) of the large two-platen electric machine.」
As an R&D achievement, the Machinery business launched a large two-platen electric machine in the 2,000-ton class. Additional specific achievements were reported in using R&D to upgrade existing businesses and create new businesses. - FY2022-Q1RestatedAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated fiscal year were ¥2,837 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current consolidated fiscal year.」
No material changes were reported in R&D activities, and first-quarter R&D expenses were ¥2,837 million. - FY2021ReframedAnnual report
「The R&D Division is also responsible for developing environment-related technologies and conducting research and development aimed at creating new businesses.」
The role of the R&D Division has been defined as covering the development of environment-related technologies in addition to the creation of new businesses. R&D expenses were ¥11,378 million, and R&D staff totaled 682. - FY2021-Q3RestatedAnnual report
「The Group’s total R&D expenses for the third quarter cumulative consolidated period were ¥8,336 million. There were no material changes in the status of the Group’s R&D activities during the third quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥8,336 million. - FY2021-Q2RestatedAnnual report
「The Group’s total R&D expenses for the second quarter cumulative consolidated period were ¥5,661 million. There were no material changes in the status of the Group’s R&D activities during the second quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported cumulative second-quarter R&D expenses of ¥5,661 million. - FY2021-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter cumulative consolidated period were ¥2,765 million. There were no material changes in the status of the Group’s R&D activities during the first quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥2,765 million. - FY2020-Q3RestatedAnnual report
「The Group’s total R&D expenses for the third quarter cumulative consolidated period were ¥9,794 million. There were no material changes in the status of the Group’s R&D activities during the third quarter cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥9,794 million. - FY2020-Q2RestatedAnnual report
「The Group’s total R&D expenses for the second quarter cumulative consolidated period were ¥6,519 million. There were no material changes in the status of the Group’s R&D activities during the second quarter cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and reported cumulative second-quarter R&D expenses of ¥6,519 million. - FY2020-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter cumulative consolidated period were ¥3,231 million. There were no material changes in the status of the Group’s R&D activities during the first quarter cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥3,231 million. - FY2019RestatedAnnual report
「The company is consolidating research related to existing businesses under the respective business divisions while strengthening collaboration among research, development, technology, and sales, aligning business objectives, clarifying the responsibility structure, and accelerating R&D. The R&D Division is specializing in research and development aimed at creating new businesses.」
The structure of consolidating existing-business research under the respective business divisions and specializing the R&D Division in creating new businesses continues. R&D staff totaled 787, and R&D expenses were ¥12,100 million. - FY2019-Q3RestatedAnnual report
「The Group’s total R&D expenses for the third quarter cumulative consolidated period were ¥9,074 million. There were no material changes in the status of the Group’s R&D activities during the third quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥9,074 million. - FY2019-Q2RestatedAnnual report
「The Group’s total R&D expenses for the second quarter cumulative consolidated period were ¥5,989 million. There were no material changes in the status of the Group’s R&D activities during the second quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported cumulative second-quarter R&D expenses of ¥5,989 million. - FY2019-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter cumulative consolidated period were ¥3,291 million. There were no material changes in the status of the Group’s R&D activities during the first quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥3,291 million. - FY2018AdvancedAnnual report
「Beginning with the current consolidated fiscal year, the company decided to consolidate research related to existing businesses, which had been conducted by the R&D Division, under each business division, while specializing the R&D Division in research and development aimed at creating new businesses. This is intended to further strengthen collaboration among research, development, technology, and sales, align business objectives, clarify the responsibility structure, and accelerate R&D.」
The company implemented an organizational change that consolidated existing-business research under the respective business divisions and specialized the R&D Division in creating new businesses. R&D staff totaled 830, and R&D expenses were ¥13,206 million. - FY2018-Q3RestatedAnnual report
「The Group’s total R&D expenses for the third quarter cumulative consolidated period were ¥9,818 million. There were no material changes in the status of the Group’s R&D activities during the third quarter cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and reported cumulative third-quarter R&D expenses of ¥9,818 million. - FY2018-Q2RestatedAnnual report
「The Group’s total R&D expenses for the second quarter cumulative consolidated period were ¥6,448 million. There were no material changes in the status of the Group’s R&D activities during the second quarter cumulative consolidated period.」
The company reaffirmed that there were no material changes in its R&D activities and reported cumulative second-quarter R&D expenses of ¥6,448 million. - FY2018-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter cumulative consolidated period were ¥3,342 million. There were no material changes in the status of the Group’s R&D activities during the first quarter cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and reported quarterly R&D expenses of ¥3,342 million. - FY2017-Q3RestatedAnnual report
「The Group’s total R&D expenses for the third quarter cumulative consolidated period were ¥10,017 million. In July 2016, the company opened the Osaka R&D Center at the Sakai Plant in the Osaka area, in addition to its R&D bases in the Yamaguchi and Chiba areas, as an R&D base for functional products to support future business expansion.」
R&D expenses for the cumulative third quarter were reported at ¥10,017 million, and the policy of utilizing the Osaka R&D Center was reiterated. The center’s opening had already been disclosed in the previous quarter, and no new progress such as the opening of another center was indicated. - FY2017-Q2AdvancedAnnual report
「The Group’s total R&D expenses for the second quarter cumulative consolidated period were ¥6,579 million. In July 2016, the company opened the Osaka R&D Center at the Sakai Plant in the Osaka area, in addition to its R&D bases in the Yamaguchi and Chiba areas, as an R&D base for functional products to support future business expansion.」
The Osaka R&D Center was opened in July 2016, expanding the company’s R&D bases. R&D expenses for the cumulative second quarter were reported at ¥6,579 million. - FY2017-Q1RestatedAnnual report
「The Group’s total R&D expenses for the first quarter cumulative consolidated period were ¥3,314 million. There were no material changes in the status of the Group’s R&D activities during the first quarter cumulative consolidated period.」
R&D activities continued, with quarterly R&D expenses reported at ¥3,314 million. There were no material changes in the status of the activities. - FY2016First statedAnnual report
「The Group’s research and development activities are aimed at advancing the manufacturing technologies of existing businesses, expanding businesses in adjacent and related fields, creating new businesses in new fields, and strengthening core technologies from a long-term perspective.」
The company reported 842 R&D staff, approximately 8% of total employees, and R&D expenses of ¥13,705 million.